TELMIKIND-TRIO 6.25

About

Telmikind-Trio 6.25 is a sophisticated combination medication specifically formulated for the comprehensive management of essential hypertension, particularly in patients whose blood pressure is not adequately controlled by dual therapy. This triple-action regimen integrates Telmisartan, an angiotensin II receptor blocker (ARB), Amlodipine, a dihydropyridine calcium channel blocker (CCB), and Hydrochlorothiazide, a thiazide diuretic. Telmisartan works by selectively blocking the AT1 receptor, thereby inhibiting the potent vasoconstrictive and aldosterone-secreting effects of angiotensin II, leading to effective vasodilation and a reduction in systemic vascular resistance. Amlodipine contributes by relaxing vascular smooth muscle through the inhibition of calcium ion influx, primarily targeting peripheral arterioles to induce vasodilation and decrease afterload. Concurrently, Hydrochlorothiazide enhances the excretion of sodium and water by inhibiting sodium reabsorption in the distal convoluted tubule, which reduces plasma volume and further lowers blood pressure. This synergistic approach addresses multiple physiological pathways involved in hypertension, providing robust and sustained blood pressure control and offering significant cardiovascular protection.

Uses

• Treatment of essential hypertension.
• Management of high blood pressure when monotherapy or dual therapy is insufficient.
• Reduction of cardiovascular risk in hypertensive patients.
• Prevention of complications associated with uncontrolled hypertension.

Directions For Use

Take orally once daily, preferably at the same time each day, with or without food, as directed by your physician.

Benefits

• Comprehensive and potent blood pressure reduction.
• Addresses multiple mechanisms of hypertension.
• Convenient once-daily dosing regimen.
• Improved patient adherence due to combination therapy.
• Potential for enhanced cardiovascular protection.
• Effective for patients unresponsive to dual therapy.

Side Effects

• Dizziness or lightheadedness
• Headache
• Fatigue
• Peripheral edema (swelling of ankles/feet)
• Nausea or abdominal discomfort
• Cough (less common than ACE inhibitors)
• Hypotension (low blood pressure)
• Electrolyte imbalances (e.g., hypokalemia, hyponatremia)
• Increased urination
• Muscle cramps or weakness
• Palpitations
• Orthostatic hypotension

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it can enhance the blood pressure-lowering effect and increase the risk of dizziness or fainting.
• Pregnancy - Contraindicated during pregnancy, especially in the second and third trimesters, due to potential fetal harm and toxicity.
• Breastfeeding - Not recommended during breastfeeding as components may pass into breast milk and could harm the infant. Consult a doctor.
• Liver - Use with caution in patients with hepatic impairment; dose adjustments may be necessary, and liver function should be monitored.
• Kidney - Use with caution in patients with severe renal impairment; regular monitoring of kidney function and electrolytes is essential.
• Lung - Generally safe, but diuretics can rarely exacerbate fluid imbalances that might affect lung function in susceptible individuals.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.